Timothy Eugene Sullivan - 18 Apr 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Financial Officer
Signature
/s/ David Watson, attorney-in-fact for Timothy Sullivan
Issuer symbol
APLS
Transactions as of
18 Apr 2024
Net transactions value
$0
Form type
4
Filing time
19 Apr 2024, 19:27:06 UTC
Previous filing
02 Apr 2024
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Gift $0 -14,164 -15% $0.000000 79,174 18 Apr 2024 Direct
transaction APLS Common Stock Gift $0 +14,164 +25% $0.000000 70,396 18 Apr 2024 Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023) F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 18, 2024, the reporting person transferred 14,164 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.